DeepIntent Wins Best Buy-Side Programmatic Platform in 2020 Digiday Technology Awards

NEW YORK, November 17, 2020 – DeepIntent, the leading healthcare marketing technology company purpose-built to influence positive health outcomes, today announced that its healthcare demand-side platform (DSP) won Best Buy-Side Programmatic Platform in the 2020 Digiday Technology Awards. The awards recognize the technology bringing transparency, efficiency, and effectiveness to the media and marketing processes for brands, agencies and publishers. DeepIntent was a finalist against leading advertising and marketing technology companies such as Xandr, Verizon Media, Cognitiv, Liftoff and Smadex.

“We’re honored to be awarded by Digiday for the success of our healthcare DSP,” said Chris Paquette, co-founder, and chief executive officer, DeepIntent. “Healthcare marketers have unique requirements around data use, inventory, and reporting underpinned by strict adherence to privacy regulations and specialized integrations for targeting and reporting. They require a platform like the DeepIntent Healthcare DSP to address their unique requirements in an effective, efficient, privacy-safe, and transparent way.”

Launched in 2019 with more than ten major pharmaceutical brands, the DeepIntent Healthcare Marketing Platform removes the complexities inherent in planning and activating data-driven campaigns. It orchestrates data deliveries and coordinates vendor list matches by centralizing and connecting all campaign activities within a single platform. Its applications— Planner and the DSP—work in harmony so marketers can quickly and easily create strategic audiences, address them immediately, and measure and optimize campaigns in-flight. By providing access to over 1.6 million verified healthcare providers and over 300 million patients, healthcare marketers can find their most clinically-relevant audiences with speed and precision.

This honor comes off the back of DeepIntent CEO and Co-Founder, Chris Paquette, winning PM360’s 2020 Trailblazer Vanguard Award for his work in creating an industry-first healthcare-specific programmatic platform.

About DeepIntent

Conceived by former Memorial Sloan Kettering data scientists, DeepIntent connects healthcare companies with patients and providers across every screen through unique data, premium media partnerships, and custom integrations. From campaign planning to audience targeting to outcomes measurement, DeepIntent is proven to increase script lift by 10% or more while improving the quality of life for patients. Powered by MarketMatch®, DeepIntent’s Healthcare Marketing Platform enables over 20 major pharmaceutical companies and dozens of media agencies to advertise to more than 200 healthcare brands, so health and treatment decisions are made based on the latest, most pertinent information. For more information, visit deepintent.com.

Press Contact

Finn Partners for DeepIntent

Zander Wharton

deepintent@finnpartners.com

203-733-2815

More News

Innovating with intent a pharma-focused CTV forum
Press Release
DeepIntent’s “Innovating with Intent” Summit Highlights the Future of CTV in Pharma
Leading ad tech innovators and thought leaders from companies including Publicis Health Media, LiveRamp, VAB, FreeWheel, DoubleVerify, LG Ads Solutions, and more joined DeepIntent...
Read More
Patient signs in at doctor's office
Press Release
DeepIntent Becomes First Demand Side Platform to Offer a Patient Reach Guarantee
Programmatic campaigns conducted on the DeepIntent platform are now guaranteed to reach verified patient audiences for specific health conditions across CTV, display, and digital...
Read More
Press Release
Fluent Joins DeepIntent’s Audience Marketplace with Permissioned Data for Healthcare Marketers
Self-declared health and wellness data will enable more efficient cross-platform targeting initiatives NEW YORK, March 22, 2022 – Fluent, Inc., a leading data-driven, performance...
Read More
Back to Top